PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Ermenegildo Zegna N.V._August_2022_153_87153 - Ermenegildo Zegna | Presentation Nation

HomepageErmenegildo ZegnaErmenegildo Zegna N.V._August_2022_153_87153

Ermenegildo Zegna N.V._August_2022_153_87153

Ermenegildo Zegna

Browse presentations, reports, and documents from Ermenegildo Zegna.

Tags

2022

Filter options

All (8)●
brochure (1)○
presentation (6)○
report (1)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

Ermenegildo Zegna N.V._August_2022_153_87153 by Ermenegildo Zegna.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Ermenegildo Zegna

ERMENEGILDO-ZEGNA-GROUP-INVESTOR-PRESENTATION

presentation

Ermenegildo-Zegna-Group-Project-Futuro_Investor-Presentation

presentation

Similar presentations from other companies

Bausch Health Companies_April_2021_956_68956

presentation

Bausch Health Companies

Aker Carbon Capture_July_2022_853_84853

presentation

Aker Carbon Capture

Ermenegildo-Zegna-Group_Sustainability-Report_2023

brochure

Ermenegildo Zegna N.V._April_2022_553_81553

presentation

Ermenegildo Zegna N.V._July_2024_377_102377

presentation

Ermenegildo Zegna N.V._March_2023_334_100334

presentation

Airbus%20Global%20Market%20Forecast%202023-2042%20Presentation

presentation

Airbus

Dynatrace%20Investor%20Presentation%20Q2%20FY21%20FINAL

presentation

Dynatrace Holdings

dormakaba_December_2017_895_18895

presentation

dormakaba Holding

GlaxoSmithKline_July_2022_231_85231

presentation

GlaxoSmithKline